ArticleAntimicrobial agents and chemotherapy2009
Posaconazole therapeutic drug monitoring: a reference laboratory experience.
Article in Antimicrobial agents and chemotherapy, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Pharmacokinetics of posaconazole prophylaxis of patients with acute myeloid leukemia.Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy · 2015Trial
- Prospective phase II single-center study of the safety of a single very high dose of liposomal amphotericin B for antifungal prophylaxis in patients with acute myeloid leukemia.Antimicrobial agents and chemotherapy · 2013Trial
- Therapeutic drug monitoring of posaconazole in patients with acute myeloid leukemia or myelodysplastic syndrome.Antimicrobial agents and chemotherapy · 2012Trial
- Intracellular concentrations of posaconazole in different compartments of peripheral blood.Antimicrobial agents and chemotherapy · 2010Trial
- Antifungal treatment strategies and their impact on resistance development in clinical settings.The Journal of antimicrobial chemotherapy · 2025Review
- MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses-A Multicenter, Open-Label, Randomized Comparative Trial.Open forum infectious diseases · 2024Article
- Piperazine based antimicrobial polymers: a review.RSC advances · 2021Review
- Comparative study of prophylaxis with high and low doses of voriconazole in children with malignancy.Current medical mycology · 2020Article
- Impact of Triazole Therapeutic Drug Monitoring Availability and Timing.Antimicrobial agents and chemotherapy · 2019Article
- The Rise ofFrontiers in immunology · 2019Review
- Isavuconazole Concentration in Real-World Practice: Consistency with Results from Clinical Trials.Antimicrobial agents and chemotherapy · 2018Article
- Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies.Scientific reports · 2018Observational
- Comparing Azole Plasma Trough Levels in Lung Transplant Recipients: Percentage of Therapeutic Levels and Intrapatient Variability.Therapeutic drug monitoring · 2017Article
- Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections.Clinical pharmacology : advances and applications · 2016Review
- Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.Antimicrobial agents and chemotherapy · 2014Article
- A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid.Antimicrobial agents and chemotherapy · 2014Article
- Antifungal prophylaxis with posaconazole in patients with acute myeloid leukemia: dose intensification coupled with avoidance of proton pump inhibitors is beneficial in shortening time to effective concentrations.Antimicrobial agents and chemotherapy · 2013Observational
- Determination of isavuconazole susceptibility of Aspergillus and Candida species by the EUCAST method.Antimicrobial agents and chemotherapy · 2013Article
- Reflections on the approach to treatment of a mycologic disaster.Antimicrobial agents and chemotherapy · 2013Article
- Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.Antimicrobial agents and chemotherapy · 2012Article
Corrections and comments
- Comment on
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.